Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy-Reference-Cited by-同舟云学术

Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy

Published:2017-02-10 Issue:2 Volume:12 Page:e0171539
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hradilova Nada,Sadilkova Lenka,Palata Ondrej,Mysikova Dagmar,Mrazkova Hana,Lischke Robert,Spisek Radek,Adkins Irena

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience;H Mellstedt;Lung cancer,2011

2. Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer;OV Skachkova;Experimental oncology,2013

3. Optimizing dendritic cell-based approaches for cancer immunotherapy;J Datta;The Yale journal of biology and medicine,2014

4. Immunobiology of dendritic cells;J Banchereau;Annual review of immunology,2000

5. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells;B Mukherji;Proceedings of the National Academy of Sciences of the United States of America,1995

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction;Cell Death Discovery;2023-10-23

2. Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer;Cancer Immunology, Immunotherapy;2022-05-24

3. Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines;Cancers;2021-04-01

4. Research and application of hydrostatic high pressure in tumor vaccines (Review);Oncology Reports;2021-03-23

5. Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial;Cancer Treatment and Research Communications;2021